These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3170653

  • 21. Difference in the ability of compactin and oxidized cholesterol, both known inhibitors of cholesterol biosynthesis, to suppress in vitro immune responses.
    Humphries GM.
    Cancer Res; 1981 Sep; 41(9 Pt 2):3789-91. PubMed ID: 7260948
    [Abstract] [Full Text] [Related]

  • 22. Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes.
    Tatsuno I, Tanaka T, Oeda T, Yasuda T, Kitagawa M, Saito Y, Hirai A.
    Biochem Biophys Res Commun; 1997 Dec 18; 241(2):376-82. PubMed ID: 9425279
    [Abstract] [Full Text] [Related]

  • 23. Mevalonate reverses the developmental arrest of preimplantation mouse embryos by Compactin, an inhibitor of HMG Co A reductase.
    Surani MA, Kimber SJ, Osborn JC.
    J Embryol Exp Morphol; 1983 Jun 18; 75():205-23. PubMed ID: 6886611
    [Abstract] [Full Text] [Related]

  • 24. Effects of 25-hydroxycholesterol, cholesterol, and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells.
    Larsson O, Zetterberg A.
    J Cell Physiol; 1986 Oct 18; 129(1):94-102. PubMed ID: 3760035
    [Abstract] [Full Text] [Related]

  • 25. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ.
    Exp Eye Res; 1997 Jul 18; 65(1):63-72. PubMed ID: 9237866
    [Abstract] [Full Text] [Related]

  • 26. Role of N-linked glycosylation in cell-cycle progression and initiation of DNA synthesis in tumor-transformed human fibroblasts.
    Carlberg M, Larsson O.
    Anticancer Res; 1993 Jul 18; 13(1):167-71. PubMed ID: 8476209
    [Abstract] [Full Text] [Related]

  • 27. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation.
    Chakrabarti R, Engleman EG.
    J Biol Chem; 1991 Jul 05; 266(19):12216-22. PubMed ID: 1712015
    [Abstract] [Full Text] [Related]

  • 28. Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation.
    Maltese WA, Sheridan KM.
    J Cell Physiol; 1987 Dec 05; 133(3):471-81. PubMed ID: 3693410
    [Abstract] [Full Text] [Related]

  • 29. Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.
    Carlberg M, Hjertman M, Wejde J, Larsson O.
    Exp Cell Res; 1994 Jun 05; 212(2):359-66. PubMed ID: 8187830
    [Abstract] [Full Text] [Related]

  • 30. Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors.
    Cuthbert JA, Lipsky PE.
    Int J Tissue React; 1987 Jun 05; 9(6):447-57. PubMed ID: 3448024
    [Abstract] [Full Text] [Related]

  • 31. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
    Keyomarsi K, Sandoval L, Band V, Pardee AB.
    Cancer Res; 1991 Jul 01; 51(13):3602-9. PubMed ID: 1711413
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP, Masters BA, Gregg RE, Durham SK.
    Toxicol Appl Pharmacol; 1997 Jul 01; 145(1):91-8. PubMed ID: 9221828
    [Abstract] [Full Text] [Related]

  • 33. Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene related monoterpenes.
    Schulz S, Bühling F, Ansorge S.
    Eur J Immunol; 1994 Feb 01; 24(2):301-7. PubMed ID: 8299679
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
    Peffley DM, Gayen AK.
    Arch Biochem Biophys; 1997 Jan 15; 337(2):251-60. PubMed ID: 9016820
    [Abstract] [Full Text] [Related]

  • 35. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP, Masters BA, Gregg RE, Durham SK.
    Toxicol Appl Pharmacol; 1997 Jul 15; 145(1):99-110. PubMed ID: 9221829
    [Abstract] [Full Text] [Related]

  • 36. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
    Peffley DM, Gayen AK.
    J Nutr; 2003 Jan 15; 133(1):38-44. PubMed ID: 12514264
    [Abstract] [Full Text] [Related]

  • 37. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D, Rutledge RZ, Needle SN, Galczenski HF, Neuenschwander K, Scotese AC, Maguire MP, Bush RC, Hele DJ, Bilder GE, Perrone MH.
    J Pharmacol Exp Ther; 1997 May 15; 281(2):746-52. PubMed ID: 9152381
    [Abstract] [Full Text] [Related]

  • 38. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. Magnitude and specificity.
    Panini SR, Schnitzer-Polokoff R, Spencer TA, Sinensky M.
    J Biol Chem; 1989 Jul 05; 264(19):11044-52. PubMed ID: 2567731
    [Abstract] [Full Text] [Related]

  • 39. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ.
    Clin Cancer Res; 2001 Jan 05; 7(1):158-67. PubMed ID: 11205904
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of the proliferation of the Madin-Darby canine kidney (MDCK) epithelial cell line by high-density lipoproteins and their induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
    Gospodarowicz D, Cohen DC, Massoglia SL.
    J Cell Physiol; 1983 Oct 05; 117(1):76-90. PubMed ID: 6352714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.